ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CUZ vs SBRA // EV/EBITDA & P/E VALUATION

Cousins Properties Incorporated (NYSE) VS. Sabra Health Care REIT Inc. (NASDAQ) • 15-METRIC TALLY: CUZ 4 — SBRA 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CUZ VS. SBRA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CUZ SBRA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 8.30% 5.50% +2.80 CUZ /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 9.2x — — TIE /valuation <GO>
Free Cash Flow Yield 7.47% 6.96% +0.51 CUZ /fcf-yield <GO>
Operating Margin 67.80% — — TIE /operating-margins <GO>
Net Profit Margin 4.10% 43.60% -39.50 SBRA /net-margins <GO>
Revenue Growth (YoY) 16.00% 25.40% -9.40 SBRA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 4.51% 5.78% -1.27 SBRA /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 8/9 6/9 +2.00 CUZ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 62.9 53.3 +9.60 CUZ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.96 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 99.3x 27.0x +72.30 SBRA /forward-pe <GO>
Enterprise Scale & Market Cap $4.91B $5.04B -$132.6M SBRA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CUZ REV SBRA REV CUZ GROSS % SBRA GROSS % CUZ FCF SBRA FCF
FY 2025 $993.8M $356.9M 68.4% — $357.6M $348.6M
FY 2024 $856.8M $284.6M 67.2% — $361.7M $310.5M
FY 2023 $802.9M $236.2M — — $332.2M $300.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CUZ // BETA 0.96
SBRA // BETA —